Skip to main content
Caplight Logo









Juro Sciences

Juro Sciences

Private
YokohamaHealthcare & Life Scienceshttps://www.sfgsci.com/

Last Round

Series B

Sep 4, 2025

Total Funding Raised

$11.03M

Company Overview

Juro Sciences is a biopharmaceutical company dedicated to developing innovative therapies for underactive bladder.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

underactive bladderUABtransdermal drug deliveryTDDSclinical stage biotechdrug patchdrug developmentacetylcholinesterase inhibitorbiopharmaceuticalfirst-in-class therapyurologyinvestigational drugexperimental drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Juro Sciences Comparables

Compare Juro Sciences with similar companies based on industry and business-model similarity.

Juro Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ono Pharmaceutical Co., Ltd.
78%
Otsuka Holdings
73%
Hisamitsu Pharmaceutical Co., Inc.
60%

Juro Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 4, 2025
GrantJun 17, 2024
Series AApr 8, 2024

Key People

Founding team and executive leadership

Hiroshi Nagabukuro

Chief Executive Officer

Executive Team

Akira Tanaka

Board Member, Chief Scientific Officer

Executive Team

Juro Sciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 4, 2025

    $6M round led by Miyako Capital.

  • Jun 17, 2024

    Received grant from Japan Agency for Medical Research and Development.

Juro Sciences Filings

Explore SEC and related filing metadata, where available.

Juro Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Juro Sciences's valuation, stock price, and market status.

Is Juro Sciences a public or private company?

Juro Sciences is a private company.

What is the current stock price of Juro Sciences?

Juro Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is Juro Sciences worth (valuation)?

Valuation information for Juro Sciences is not publicly available.

Can I buy Juro Sciences stock?

Juro Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Juro Sciences's last funding round?

Funding round information for Juro Sciences is not publicly available.

Who are the main investors in Juro Sciences?

Investor information for Juro Sciences is not publicly disclosed.

Will Juro Sciences IPO soon?

No public IPO plans have been announced for Juro Sciences.

How can I track Juro Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Juro Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersYokohama
Employee Range4
Year FoundedN/A
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?